What is the “Title Element” in a Sequence Listing XML?

The “Title Element,” also known as the InventionTitle element, is a required component of the “general information” part of the “Sequence Listing XML” in patent applications. According to MPEP 2413.01(i), this element “need not be in English,” and applicants can provide multiple InventionTitle elements in different languages. To learn more: Sequence Listing XML InventionTitle Patent…

Read More

How does the predictability of a technology affect enablement requirements?

The predictability of a technology significantly affects enablement requirements in patent law. Generally, less predictable technologies require more detailed disclosure to satisfy the enablement requirement. The MPEP Section 2164.06(b) provides examples illustrating this principle: In the Enzo Biochem v. Calgene case, the court noted that “antisense gene technology was highly unpredictable.” This unpredictability contributed to…

Read More

How does “supplement” differ from “replacement” in biological deposits?

While “replacement” involves substituting one deposit for another, “supplement” refers to situations where the original deposit is still viable but has lost certain qualities. The MPEP explains: “The term ‘supplement’ is directed to those situations where the earlier deposit is still viable in the sense that it is alive and capable of replication either directly…

Read More

What are the Sequence Rules in patent applications?

The Sequence Rules are a set of regulations that define how nucleotide and amino acid sequences must be presented in patent applications. According to MPEP 2421.02, these rules “define a set of symbols and procedures that are both mandatory and the only way that an applicant is permitted to describe information in the ‘Sequence Listing’…

Read More

What is the root element requirement for a “Sequence Listing XML” in patent applications?

The “Sequence Listing XML” in patent applications filed on or after July 1, 2022, must contain a root element as defined in paragraph 43 of WIPO Standard ST.26. This requirement is specified in 37 CFR 1.833(b)(2)(iii). The root element must include several attributes, as stated in the MPEP: “WIPO Standard ST.26, paragraph 43, proscribes the…

Read More

What is a “Sequence Listing XML” and when is it required?

A “Sequence Listing XML” is a standardized format for presenting nucleotide and/or amino acid sequences in patent applications. It is required for all applications filed on or after July 1, 2022, that have disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b). The XML format ensures that sequence information is machine-readable…

Read More